2417649-44-4
2417649-44-4
Chemical Structure
Tuvonralimab
Synonym(s): PSB-205; QL1706 (iparomlimab/tuvonralimab); PBS105
- CAS No.: 2417649-44-4
- Formula:N/A
- Molecular Weight:(145 kDa)
IUPAC Name: 2-((4-methylpentan-2-yl)amino)-5-((phenyl-d5)amino)cyclohexa-2,5-diene-1,4-dione
SMILES: [Tuvonralimab]
Biological Activity: Tuvonralimab (PSB-205) is a humanized IgG1 monoclonal antibody against CTLA-4. Tuvonralimab can be used in the research of tumors. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001)[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Tuvonralimab | 99.14% | Tuvonralimab (PSB-205) is a humanized IgG1 monoclonal antibody against CTLA-4. Tuvonralimab can be used in the research of tumors. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Ian Wilkinson, et al. Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names. MAbs. 2022 Jan-Dec;14(1):2123299. [Content Brief]
- [2]. Keam SJ. Iparomlimab and Tuvonralimab: First Approval. Drugs. 2025 May;85(5):699-706. [Content Brief]
